Laura Adams

Laura Adams, Senior Advisor at the National Academy of Medicine (NAM), provides strategic advising for the Science and Technology portfolio of the Leadership Consortium and leads the NAM’s Artificial Intelligence Code of Conduct (AICC) national initiative. Her expertise is in digital health, the science of improvement, and human-centered care. She chairs the Global Opportunities Group for the Regulatory Science and Innovation Network in AI and Digital Health in the UK.

 

Laura serves on the boards of Boston-based T2 Biosystems and TMA Precision Health; and the Steering Committee of the Coalition for Health AI (CHAI); She is a strategic advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in transcriptomics/host immune response diagnostics.

 

Laura chaired the Institute of Medicine’s (IOM) Planning Committee for the “Digital Infrastructure for the Learning Healthcare System” initiative. She is recognized as a strategic leader of large scale multisectoral initiatives with a deep experience in and understanding of the complex U.S. health care industry, including how the components function and interact.

 

Laura was among the first to bring the principles of healthcare quality improvement to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. She served as Institute for Healthcare Improvement (IHI) faculty at the inaugural IHI Middle East Forum on Quality Improvement in Healthcare in Doha, Qatar.  

 

Laura was founding President and CEO of the Rhode Island Quality Institute (RIQI), Rhode Island’s statewide health information exchange. Under her leadership, RIQI won the National Council for Community Behavioral Health Excellence Award for Impact in serving those with behavioral health and substance abuse challenges.  RIQI was the recipient of the national Healthcare Informatics Innovation Award for impact on the opioid crisis; and was a top finalist for the New England Business Innovation award.